Influence of aerobic exercise training on cardiovascular and endocrine-inflammatory biomarkers in hypertensive postmenopausal women.

Aline P Jarrete, Iane P Novais, Hygor A Nunes, Guilherme M Puga, Maria A Delbin, Angelina Zanesco
Author Information
  1. Aline P Jarrete: Laboratory of Cardiovascular Physiology and Exercise Science, University of São Paulo State (UNESP), Av, 24 A, 1515, Rio Claro, SP CEP: 13506-900, Brazil.
  2. Iane P Novais: Laboratory of Cardiovascular Physiology and Exercise Science, University of São Paulo State (UNESP), Av, 24 A, 1515, Rio Claro, SP CEP: 13506-900, Brazil.
  3. Hygor A Nunes: Laboratory of Cardiovascular Physiology and Exercise Science, University of São Paulo State (UNESP), Av, 24 A, 1515, Rio Claro, SP CEP: 13506-900, Brazil.
  4. Guilherme M Puga: Laboratory of Cardiovascular Physiology and Exercise Science, University of São Paulo State (UNESP), Av, 24 A, 1515, Rio Claro, SP CEP: 13506-900, Brazil.
  5. Maria A Delbin: Department of Structural and Functional Biology, Biology Institute, UNICAMP, Campinas, SP, Brazil.
  6. Angelina Zanesco: Laboratory of Cardiovascular Physiology and Exercise Science, University of São Paulo State (UNESP), Av, 24 A, 1515, Rio Claro, SP CEP: 13506-900, Brazil.

Abstract

Given that few studies have examined the interaction between endocrine-inflammatory mediators and aerobic exercise training in hypertensive postmenopausal women, the aim of this study was to investigate whether aerobic exercise training (AET) for twenty-four sessions would alter cortisol, leptin and interleukin-1β (IL-1β) levels. To further analyze endothelium function in response to AET, we also examined redox state as well as NO/cGMP pathway in this population. Eighteen hypertensive postmenopausal women finished this study. AET program consisted of 24 sessions in treadmill, 3 times per week, duration of 30 up to 40 min for each session, for 8 weeks at intensity of 100% of the MLSS according to previous incremental test. Heart rate was monitored in all studied time (resting and during exercise sessions). After 48 h of the last exercise session, blood samples were collected for biochemical analyses (levels of cortisol, leptin, IL-1β, nitrite/nitrate (NOx), cGMP, malondialdehyde (MDA) and asymmetric dimethylarginine (ADMA); superoxide and catalase activity). We also measured systolic and diastolic blood pressure. A significant reduction in body mass was observed. As expected, systolic and diastolic blood pressure values were significantly reduced after AET in hypertensive women. We also found a marked increase in NOx levels as well as cGMP concentration in trained women, approximately 37.7 and 30.8%, respectively. No changes in cortisol, leptin, ADMA and IL-1β levels were observed after AET. Similarly, MDA levels and catalase activity were not affected by AET. In contrast, a marked increase in SOD activity was found (86.6%). In conclusion, our findings show that aerobic exercise training for twenty-four sessions promoted a significant reduction in blood pressure by activating NO/cGMP pathway as well as by promoting an up-regulation of SOD activity without changing in cortisol/leptin levels in postmenopausal hypertensive women.

Keywords

References

  1. Metabolism. 2006 Dec;55(12):1630-6 [PMID: 17142136]
  2. Ann Behav Med. 2003 Dec;26(3):212-20 [PMID: 14644697]
  3. Med Sci Sports Exerc. 1995 Jun;27(6):863-7 [PMID: 7658947]
  4. Gynecol Endocrinol. 2011 Oct;27(10):794-9 [PMID: 21736538]
  5. Endocrinol Metab Clin North Am. 2011 Jun;40(2):393-407, ix [PMID: 21565674]
  6. Am J Hypertens. 2013 Mar;26(3):416-23 [PMID: 23382493]
  7. Menopause. 2014 Apr;21(4):424-32 [PMID: 24149922]
  8. Pharmacol Ther. 2007 Jun;114(3):307-17 [PMID: 17512599]
  9. Endocr Rev. 2007 Aug;28(5):521-74 [PMID: 17640948]
  10. Bone. 2001 Jul;29(1):30-4 [PMID: 11472888]
  11. Clin Exp Hypertens. 1997 May;19(4):479-93 [PMID: 9140709]
  12. J Clin Endocrinol Metab. 1996 Sep;81(9):3424-7 [PMID: 8784109]
  13. Clin Sci (Lond). 2013 Oct;125(7):311-8 [PMID: 23746374]
  14. Int J Obes Relat Metab Disord. 2000 Jan;24(1):27-32 [PMID: 10702747]
  15. Biol Res Nurs. 2014 Jan;16(1):38-45 [PMID: 24057220]
  16. Eur Heart J. 2013 Jun;34(24):1790-9 [PMID: 23569199]
  17. Clin Exp Pharmacol Physiol. 2007 Dec;34(12):1317-8 [PMID: 17973874]
  18. Circ J. 2003 Apr;67(4):305-11 [PMID: 12655160]
  19. Rev Bras Ginecol Obstet. 2009 May;31(5):254-61 [PMID: 19669034]
  20. BMC Womens Health. 2009 Jun 19;9:17 [PMID: 19545388]
  21. PLoS One. 2012;7(12):e53318 [PMID: 23285277]
  22. Arch Gerontol Geriatr. 2009 Jul-Aug;49(1):e67-71 [PMID: 18990458]
  23. Maturitas. 2007 Apr 20;56(4):396-403 [PMID: 17164077]
  24. Clin Exp Pharmacol Physiol. 2005 Mar;32(3):162-6 [PMID: 15743397]
  25. Am J Hypertens. 2014 Mar;27(3):415-21 [PMID: 24280041]
  26. Maturitas. 2002 Mar 25;41(3):187-92 [PMID: 11886764]
  27. J Clin Endocrinol Metab. 2006 Dec;91(12):4805-8 [PMID: 17018658]
  28. Circ J. 2013;77(2):281-92 [PMID: 23328449]
  29. J Steroid Biochem Mol Biol. 1992 Oct;43(5):409-13 [PMID: 1390289]
  30. Physiol Genomics. 2008 Jan 17;32(2):254-63 [PMID: 17986523]
  31. Hypertension. 2001 May;37(5):1199-208 [PMID: 11358929]
  32. Eur J Clin Invest. 2005 Oct;35(10 ):622-6 [PMID: 16178881]
  33. Life Sci. 2014 Jul 11;108(1):30-3 [PMID: 24825610]
  34. J Hypertens. 1999 Dec;17(12 Pt 1):1715-23 [PMID: 10658937]
  35. Hypertens Res. 2007 Dec;30(12):1159-67 [PMID: 18344620]
  36. Mayo Clin Proc. 2012 Oct;87(10):944-52 [PMID: 23036670]
  37. Menopause. 2000 May-Jun;7(3):149-55 [PMID: 10810959]
  38. Biol Res Nurs. 2002 Jul;4(1):16-21 [PMID: 12363278]
  39. Eur J Appl Physiol. 2003 Mar;89(1):95-9 [PMID: 12627312]
  40. Psychosom Med. 2011 Sep;73(7):604-11 [PMID: 21873586]
  41. Methods Mol Biol. 1998;108:101-6 [PMID: 9921519]
  42. Br J Sports Med. 2012 Aug;46(10):753-8 [PMID: 21947813]
  43. Int J Obes Relat Metab Disord. 2000 Nov;24(11):1438-44 [PMID: 11126340]
  44. Nutr J. 2007 Oct 25;6:31 [PMID: 17961235]
  45. Prev Med. 1995 Sep;24(5):509-17 [PMID: 8524727]
  46. Maturitas. 2006 Jan 10;53(1):77-82 [PMID: 16325025]
  47. Ann Epidemiol. 1998 Jan;8(1):39-45 [PMID: 9465992]
  48. Cardiovasc Res. 1999 Aug 15;43(3):542-8 [PMID: 10690326]
  49. Braz J Med Biol Res. 2011 Sep;44(9):855-63 [PMID: 21956531]
  50. Eur J Cardiovasc Prev Rehabil. 2010 Dec;17(6):676-81 [PMID: 20436351]
  51. Vasc Health Risk Manag. 2005;1(4):291-9 [PMID: 17315601]
  52. J Hypertens. 2002 Jun;20(6):1035-43 [PMID: 12023661]
  53. Clin Exp Pharmacol Physiol Suppl. 1998 Nov;25:S51-6 [PMID: 9809193]
  54. Nutr Rev. 2009 Apr;67(4):213-21 [PMID: 19335715]
  55. Fertil Steril. 2009 Feb;91(2):425-31 [PMID: 18249383]

Word Cloud

Created with Highcharts 10.0.0exercisewomenAETlevelshypertensiveaerobictrainingpostmenopausalsessionsbloodactivitypressurecortisolleptinIL-1βalsowellpathwayexaminedendocrine-inflammatorystudytwenty-fourstateNO/cGMP30sessionNOxcGMPMDAADMAcatalasesystolicdiastolicsignificantreductionobservedfoundmarkedincreaseSODGivenstudiesinteractionmediatorsaiminvestigatewhetheralterinterleukin-1βanalyzeendotheliumfunctionresponseredoxpopulationEighteenfinishedprogramconsisted24treadmill3timesperweekduration40 min8weeksintensity100%MLSSaccordingpreviousincrementaltestHeartratemonitoredstudiedtimeresting48 hlastsamplescollectedbiochemicalanalysesnitrite/nitratemalondialdehydeasymmetricdimethylargininesuperoxidemeasuredbodymassexpectedvaluessignificantlyreducedconcentrationtrainedapproximately3778%respectivelychangesSimilarlyaffectedcontrast866%conclusionfindingsshowpromotedactivatingpromotingup-regulationwithoutchangingcortisol/leptinInfluencecardiovascularbiomarkersBloodCortisolLeptinNitricoxideRedox

Similar Articles

Cited By (15)